Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab

A 72-year-old woman with advanced lung cancer had received systemic chemotherapy including atezolizumab. About three months after the initial administration of atezolizumab, her liver enzyme levels increased. The histopathological findings of the initial liver biopsy revealed acute inflammatory infi...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, Yuichi, Shibata, Michihiko, Gohda, Tomonori, Matsumiya, Hiroki, Kumamoto, Keiichiro, Miyama, Aya, Morino, Kahori, Koya, Yudai, Taira, Akihiro, Shinohara, Shinji, Hayashi, Tsuguru, Kusanaga, Masashi, Oe, Shinji, Miyagawa, Koichiro, Abe, Shintaro, Tanaka, Fumihiro, Harada, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263175/
https://www.ncbi.nlm.nih.gov/pubmed/33456046
http://dx.doi.org/10.2169/internalmedicine.6535-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263175/
https://www.ncbi.nlm.nih.gov/pubmed/33456046
http://dx.doi.org/10.2169/internalmedicine.6535-20

Ejemplares similares